Samplix ApS is SmiLe's new Lab Sponsor
Trine Overgaard Østerbye and Bárbara Schlicht from Samplix, the instrument Xdrop®, Patrick Aldrin-Kirk and Fanny Andersson from SmiLe company rAAVen, and Ulrika Ringdahl from SmiLeWe are excited to share that the innovative instrument company Samplix ApS is our new Lab Sponsor. Samplix adds their pioneering Xdrop®, a microfluidics-based instrument to SmiLe's well-equipped laboratories for drug discovery, which are available to all our member companies and also to external companies through our Open Labs.
Samplix empowers the life sciences and medical research communities with cutting-edge microfluidics-based solutions in the areas of genomics, cell screening, cell therapy, and molecular engineering workflows. With the addition of Samplix's Xdrop platform at SmiLe's labs, we can now offer an even more advanced research environment for drug discovery companies, providing researchers with unparalleled insights into the intricate world of cells and genomes.
The Xdrop platform uses microfluidics technology to encapsulate biomolecules or single cells in double-emulsion droplets, that act as micro-scale incubators and retain excreted molecules. This approach enables a wide range of single-cell functional high-throughput assays and genomic analyses. Compatible with both flow cytometers and sorters, Xdrop offers a versatile solution for molecular analysis.
Samplix is committed to supporting the companies prior to and during their use of the instrument. This includes comprehensive training and ongoing support, as well as assistance with assay development and optimization.
“Sponsoring the SmiLe Incubator is an investment in the future of life science innovation. By providing companies at SmiLe access and support to essential technology such as Samplix's Xdrop, we are not only fostering the growth of groundbreaking startups but also contributing to a vibrant ecosystem. Together, we are propelling life sciences innovation,” says Bárbara Schlicht, Product manager at Samplix.
“We are very proud to now be able to offer this cutting-edge instrument to the companies. This innovative technology can reveal previously hidden heterogeneity within samples, a feature that is particularly valuable to our ATPM companies,” says Ulrika Ringdahl, COO of SmiLe.
For more information, please contact: Ulrika Ringdahl, COO of SmiLe, +46 (0) 736 566 232, ulrika.ringdahl@smileincubator.life
Information about Samplix: www.samplix.com
About SmiLe Venture Hub – Pioneering Life Science Innovations
SmiLe is a leading venture hub that specializes in advancing life science startups from concept to commercialization. We offer comprehensive support through every stage of entrepreneurship, including tailored incubation and acceleration programs, a variety of educational courses, and access to top-tier lab facilities. To date, our flagship incubator program has supported over 100 startups, facilitating their collective acquisition of more than EUR 841 million in venture capital and contributing to 21 successful IPOs. Recognized as one of Europe’s leading startup hubs in 2024 by the Financial Times and Statista, SmiLe continues to be a catalyst for innovation in the life sciences sector. As a non-profit entity based in Lund, Sweden, SmiLe is supported by Region Skåne, Lund Municipality, Lund University, and Medicon Village. We are also backed by our sponsors Agilent, Sparbanken Skåne, Høiberg, Setterwalls, Zacco, Key2Compliance, Phase Holographic Imaging, and ChemoMetec. For more information: www.smileventurehub.com
Powered by Notified